Overview
At Sabinsa, research and innovation are the foundation of everything we do. We draw from the rich diversity of Mother Nature and apply rigorous science to transform botanical discoveries into high-quality, evidence-based ingredients. We are guided at every stage by our philosophy of “Design to Delivery,” from initial discovery through commercial launch.
Our multidisciplinary R&D teams span new product development, process optimization, quality improvement, and manufacturing efficiency. By integrating expertise across scientific disciplines, we develop standardized ingredients that meet the highest international standards for quality, safety, and performance. This approach has produced a strong portfolio of patented ingredients and earned numerous national and international awards for scientific excellence. We deliver solutions that benefit our customers and the broader health and wellness industry worldwide.
CORPORATE R&D CENTER, PEENYA, BENGALURU
This strategic decision-making center houses the core R&D and Administrative/ Executive facility. Several of Sabinsa’s innovative products were conceived in these laboratories and have since been successfully commercialized.
PHYTOCHEMISTRY
The Phytochemistry Division is the cornerstone of Sabinsa’s R&D organization, with primary responsibility for developing and optimizing extraction processes that yield standardized botanical extracts from carefully selected natural sources. The team specializes in the identification, isolation, and characterization of bioactive compounds, and has developed and commercialized a broad portfolio of standardized phytoextracts for nutraceutical, cosmeceutical, and nutricosmetic applications. Several of Sabinsa’s innovative products were conceived in these laboratories and have since been successfully commercialized.
The laboratory is equipped with advanced analytical instrumentation, including a Nikon Eclipse Ci microscope with a Nikon DS-Ri2 digital camera, as well as a comprehensive suite of research equipment supporting rigorous phytochemical analysis. The division collaborates closely with Sabinsa’s Pharmacognosy Department, which authenticates botanical raw materials through detailed morphological and microscopic evaluation to ensure quality, identity, and consistency throughout the supply chain.
SYNTHETIC CHEMISTRY
The Synthetic Chemistry Department is dedicated to the discovery and development of novel bioactive molecules for pharmaceutical, nutraceutical, and cosmetic applications. Its research encompasses a diverse range of compounds, including peptides, carbohydrates, natural products, peptide–natural product hybrids, chiral molecules, analytical reference standards, and other specialty chemicals, with ongoing additions expanding the Sami-Sabinsa’s portfolio.
Beyond molecular discovery, the department develops efficient, scalable, and environmentally responsible synthetic processes. Scientists continually optimize synthetic routes to improve manufacturing efficiency, reduce production costs, and support sustainable scale-up from laboratory to pilot and commercial production. The department’s research excellence is reflected in its extensive portfolio of scientific publications and patents.
The team also provides custom synthesis services for naturally derived compounds, metabolites, and other organic molecules to support pharmaceutical research, analytical applications, and biophysical studies. Through collaborations with leading research institutes, universities, and industry partners in India and around the world, the department contributes its expertise to advancing scientific innovation across multiple disciplines.
TISSUE CULTURE
The Plant Tissue Culture Division focuses on the micropropagation of high-performing plant varieties with significant bioactive potential, as well as the conservation and propagation of select rare and valuable botanical species using advanced tissue culture techniques.
The division’s development process encompasses four key stages:
- Identifying and selecting high-yielding plant varieties
- Rapidly multiplying elite plants through tissue culture technology
- Conducting field trials to evaluate plant performance and consistency
- Supplying high-quality planting material to contract farmers for large-scale commercial cultivation
To date, the division has successfully propagated important botanical species including Coleus forskohlii, Curcuma longa (turmeric), and Allium sativum (garlic). Ongoing research includes the development of callus culture systems for the production of valuable secondary metabolites, supporting sustainable cultivation and long-term ingredient innovation.
AGRI-BIOTECHNOLOGY
The Agri-Biotechnology Division is dedicated to identifying and developing elite genotypes of high-value botanical and aromatic plants while ensuring a reliable supply of superior planting material optimized for commercial cultivation in specific climatic regions. Its work spans germplasm selection, agronomic research, post-harvest technology development, and the transfer of these innovations to farmers through contract cultivation partnerships.
Guided by the principle that “cultivation leads to conservation,” the team promotes sustainable agriculture by reducing dependence on wild plant populations. Sami-Sabinsa pioneered the large-scale commercial cultivation of Coleus forskohlii across thousands of acres in India, followed by successful cultivation programs for turmeric (Curcuma longa), amla (Phyllanthus emblica), tulsi (Ocimum sanctum), and other botanicals. The successful transition of Coleus forskohlii from wild harvesting to cultivated production has helped ensure the long-term sustainability and conservation of this valuable resource.
The division also prioritizes the development of concentrated, science-backed botanical extracts for nutritional applications, and has developed modified hydroponic techniques to naturally enhance crop micronutrient content, including iron- and zinc-enriched green gram and selenium-enriched garlic. These advances have been successfully translated into commercially available products.
ANALYTICAL R&D
The Analytical R&D Division is a central pillar of Sami-Sabinsa’s quality and innovation programs. Accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL), the laboratory employs validated analytical methods and internationally recognized testing protocols to ensure the quality, safety, and consistency of ingredients and finished products.
The facility is equipped with a comprehensive range of advanced instrumentation, including HPLC, GC, LC-MS, LC-MS/MS, GC-MS, GC-MS/MS, HPTLC, ICP-MS, FTIR with HATR, CHNS elemental analysis, and 300 MHz NMR spectroscopy, enabling precise identification, characterization, and quantification of botanical extracts, bioactive compounds, and novel molecules.
Core responsibilities of the team include:
- Developing and validating analytical methods
- Quantifying bioactive compounds and verifying assay and purity
- Testing for heavy metals, residual solvents, and pesticide residues
- Evaluating physical and chemical parameters against established specifications
- Conducting recovery studies and analytical evaluations of finished formulations
BIOLOGICAL RESEARCH
The Biological Research Division of Sami-Sabinsa is NABL-accredited and specializes in evaluating the safety and efficacy of ingredients using advanced in vitro methods, consistent with a commitment to animal-free testing.
The division has assessed a wide range of phytoingredients and cosmeceuticals through a comprehensive suite of in vitro assays. The laboratory is equipped with flow cytometry and RT-PCR systems to support high-quality biological research across multiple study areas, including:
- Dermal irritation studies
- Ocular irritation studies
- Cytotoxicity assessments
- Mutagenicity testing
MICROBIOLOGY
The Microbiology Division develops and validates microbial testing methods for new product development in accordance with Good Laboratory Practice (GLP) requirements, providing analytical support to R&D across the organization. The team conducts microbiological quality testing for herbal and synthetic active ingredients, nutraceutical and cosmeceutical formulations, probiotics, and related products.
Additional capabilities include preservative efficacy testing across a broad range of formulations, along with specialized research on skin and scalp microbial balance, including studies related to blemish-prone skin and scalp flaking.
The laboratory operates within a Class 10,000 cleanroom environment and is equipped with laminar airflow units, biosafety cabinets, anaerobic chambers, bacteriological and BOD incubators, autoclaves, and hot air ovens, ensuring the highest standards of sterility and analytical precision.
BIOTECHNOLOGY
The Biotechnology Division specializes in the development of stable probiotics and enzyme complexes, with a focus on biocatalytic processes that enhance the recovery and bioavailability of bioactive compounds. Research spans microbial discovery, strain improvement, process optimization, and scale-up for industrial and therapeutic applications.
Core areas of expertise include:
- Isolation, identification, and screening of microorganisms with industrial and therapeutic potential
- Development and optimization of high-yield microbial strains for protein and enzyme production
- Biocatalytic conversion, enzyme-mediated biotransformation, and chiral resolution for value-added products
- Optimization of culture media and scale-up studies for therapeutic proteins, enzymes, and probiotics
- Cultivation of mineral-enriched yeast and bacterial cultures for probiotic and functional food applications
SUPER CRITICAL FLUID EXTRACTION (SCFE)
The Supercritical Fluid Extraction (SCFE) Division pioneered the commercialization of India’s first domestically developed SCFE technology, created in collaboration with the Indian Institute of Technology Bombay (IIT Bombay). The facility uses supercritical carbon dioxide (CO₂) as a clean solvent for the efficient extraction of high-value natural compounds, with a current processing capacity of approximately 45 metric tons of raw material per month. A dedicated pilot plant supports process optimization and validation prior to commercial-scale production.
The division’s R&D focus spans process development, scale-up, quality enhancement, and cost optimization, and has yielded a broad range of herbal extracts, botanical extracts, and spice oleoresins supplied to domestic and international markets.
Key advantages of supercritical CO₂ extraction:
- Operates at relatively mild temperatures, preserving heat-sensitive bioactive compounds
- Uses GRAS-designated CO₂, suitable for food, nutraceutical, and pharmaceutical applications
- Leaves no residual solvents, producing cleaner, higher-purity extracts
- Non-toxic, non-flammable, and environmentally friendly
- Readily available, recyclable, and inert toward most materials
FORMULATION R&D
The Formulation R&D Division transforms innovative bioactive ingredients into market-ready products across the nutraceutical, cosmeceutical, nutricosmetic, food, and beverage sectors. Combining scientific expertise with formulation technology, the team develops application-specific solutions that maximize the functionality, stability, and consumer appeal of each compound.
Work is organized across three areas:
- Nutraceutical and Nutricosmetic Formulations
- Cosmetic and Personal Care Formulations
- Functional Food and Beverage Formulations
The division develops prototype formulations across a broad range of dosage and delivery formats — solids, liquids, and semi-solids — including dietary supplements, functional foods and beverages, cosmetics, and personal care products. Through formulation development, optimization, and proof-of-concept prototyping, the team provides a strong technical foundation for product commercialization and supports the translation of science into market-ready solutions.
SUPPORT DIVISIONS
Sami-Sabinsa’s multidisciplinary R&D divisions are fully integrated across the product development pipeline — from the cultivation and sourcing of plant materials to the discovery, characterization, and optimization of novel bioactive ingredients. This pipeline encompasses biological efficacy studies, safety and toxicity assessments, formulation development, prototype evaluation, and customized solutions tailored to specific customer and market requirements.
Supporting these core research functions, the Regulatory Affairs and Technical Support divisions work closely with R&D, marketing, and business development teams to ensure regulatory compliance, facilitate product registrations, and deliver the scientific and technical expertise required to commercialize products in domestic and international markets.
REGULATORY AFFAIRS
The Regulatory Affairs Division ensures that Sabinsa’s products meet all applicable regulatory requirements throughout their lifecycle. Serving as a strategic link between research, product development, formulation, manufacturing, quality, clinical research, and marketing, the division integrates regulatory considerations into every stage of the development process.
From early-stage development, the team works cross-functionally to build regulatory strategies, prepare comprehensive technical documentation, and compile and submit dossiers to national and international health authorities — facilitating timely product approvals and successful market entry across multiple regions.
The division also manages interactions with regulatory agencies, coordinates scientific and regulatory meetings, prepares briefing documents and query responses, and oversees official communications throughout the review and approval process. In doing so, it supports Sabinsa’s commitment to quality, safety, and the successful commercialization of its products globally.
TECHNICAL SUPPORT
The Technical Support Division connects Sabinsa’s R&D, Quality Assurance, Manufacturing, Marketing, and Business Development teams with global customers and partners. The division ensures the accurate and timely flow of technical information across functions, addressing customer inquiries with scientific rigor and industry expertise.
Working cross-functionally, the team compiles and communicates product documentation, specifications, scientific data, and application guidance to meet customer requirements. It also contributes to new product development by providing market-driven technical insights and customer feedback, helping translate emerging industry needs into product solutions.
In addition, the division develops a broad range of techno-marketing resources, including product brochures, technical data sheets, application notes, and presentations, that support marketing and business development initiatives. The team responds to inquiries from global offices, distributors, and customers, providing application-specific recommendations and customized technical solutions that support successful product commercialization.
